18 results on '"Schirmer, Stephan H."'
Search Results
2. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure– and Heart Rate–Independent Manner.
- Author
-
Schirmer, Stephan H., Sayed, Marwa M.Y.A., Reil, Jan-Christian, Lavall, Daniel, Ukena, Christian, Linz, Dominik, Mahfoud, Felix, and Böhm, Michael
- Abstract
Objectives This study sought to investigate left atrial (LA) remodeling in relation to blood pressure (BP) and heart rate (HR) after renal sympathetic denervation (RDN). Background In addition to reducing BP and HR in certain patients with hypertension, RDN can decrease left ventricular (LV) mass and ameliorate LV diastolic dysfunction. Methods Before and 6 months after RDN, BP, HR, LV mass, left atrial volume index (LAVI), diastolic function (echocardiography), and premature atrial contractions (PAC) (Holter electrocardiogram) were assessed in 66 patients with resistant hypertension. Results RDN reduced office BP by 21.6 ± 3.0/10.1 ± 2.0 mm Hg (p < 0.001), and HR by 8.0 ± 1.3 beats/min (p < 0.001). At baseline, LA size correlated with LV mass, diastolic function, and pro-brain natriuretic peptide, but not with BP or HR. Six months after RDN, LAVI was reduced by 4.0 ± 0.7 ml/kg/m 2 (p < 0.001). LA size decrease was stronger when LAVI at baseline was higher. In contrast, the decrease in LAVI was not dependent on LV mass or diastolic function (E/E′ or E/A) at baseline. Furthermore, LAVI decreased without relation to decrease in systolic BP or HR. Additionally, occurrence of PAC (median of >153 PAC/24 h) was reduced (to 68 PAC/24 h) by RDN, independently of changes in LA size. Conclusions In patients with resistant hypertension, LA volume and occurrence of PAC decreased 6 months after RDN. This decrease was independent of BP and HR at baseline or the reduction in BP and HR reached by renal denervation. These data suggest that there is a direct, partly BP-independent effect of RDN on cardiac remodeling and occurrence of premature atrial contractions. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. Probenecid reduces infection and inflammation in acute Pseudomonas aeruginosa pneumonia.
- Author
-
Wonnenberg, Bodo, Tschernig, Thomas, Voss, Meike, Bischoff, Markus, Meier, Carola, Schirmer, Stephan H., Langer, Frank, Bals, Robert, and Beisswenger, Christoph
- Subjects
PROBENECID (Drug) ,PSEUDOMONAS aeruginosa infections ,INFLAMMATION treatment ,PNEUMONIA treatment ,PANNEXINS ,CASPASES ,INTERLEUKIN-1 ,THERAPEUTICS - Abstract
The activation of inflammasome signaling mediates pathology of acute Pseudomonas aeruginosa pneumonia. This suggests that the inflammasome might represent a target to limit the pathological consequences of acute P. aeruginosa lung infection. Pannexin-1 (Px1) channels mediate the activation of caspase-1 and release of IL-1β induced by P2X7 receptor activation. The approved drug probenecid is an inhibitor of Px1 and ATP release. In this study, we demonstrate that probenecid reduces infection and inflammation in acute P. aeruginosa pneumonia. Treatment of mice prior to infection with P. aeruginosa resulted in an enhanced clearance of P. aeruginosa and reduced levels of inflammatory mediators, such as IL-1β. In addition, probenecid inhibited the release of inflammatory mediators in murine alveolar macrophages and human U937 cell-derived macrophages upon bacterial infection but not in human bronchial epithelial cells. Thus, Px1 blockade via probenecid treatment may be a therapeutic option in P. aeruginosa pneumonia by improving bacterial clearance and reducing negative consequences of inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
4. Improvements in Left Ventricular Hypertrophy and Diastolic Function Following Renal Denervation: Effects Beyond Blood Pressure and Heart Rate Reduction.
- Author
-
Schirmer, Stephan H., Sayed, Marwa M.Y.A., Reil, Jan-Christian, Ukena, Christian, Linz, Dominik, Kindermann, Michael, Laufs, Ulrich, Mahfoud, Felix, and Böhm, Michael
- Subjects
- *
HYPERTROPHY , *DIASTOLE (Cardiac cycle) , *KIDNEY surgery , *DENERVATION , *BLOOD pressure , *HEART beat , *LEFT heart ventricle , *HYPERTENSION - Abstract
Objectives: This study sought to investigate the interaction between blood pressure (BP) and heart rate (HR) reduction and changes in left ventricular (LV) structure and function following renal sympathetic denervation (RDN). Background: Hypertension results in structural and functional cardiac changes. RDN reduces BP, HR, and LV mass and improves diastolic dysfunction. Methods: We evaluated LV size, mass, and function before and 6 months after RDN in 66 patients with resistant hypertension and analyzed results in relation to systolic BP (SBP) and HR. Results: SBP decreased by 11 ± 3 mm Hg in the first, 18 ± 5 mm Hg in the second, and 36 ± 7 mm Hg in the third tertile of SBP at baseline (p < 0.001). HR decreased by 13 ± 4 beats/min, 8 ± 3 beats/min, and 11 ± 6 beats/min in tertiles of SBP (p for interaction between tertiles = 0.314). In all SBP tertiles, LV mass index (LVMI) decreased similarly (LVMI −6.3 ± 2.2 g/m2.7, −8.3 ± 2.1 g/m2.7, and −9.6 ± 1.9 g/m2.7; p for interaction = 0.639). LVMI decreased unrelated to HR at baseline (p for interaction = 0.471). The diastolic parameters E-wave deceleration time, isovolumetric relaxation time, and E′-wave velocity improved similarly in all tertiles of SBP and HR. Changes in LV mass and function were also unrelated to reduction in SBP or HR. Vascular compliance improved dependently on BP but independently of HR reduction. Conclusions: In patients with resistant hypertension, LV hypertrophy and diastolic function improved 6 months after RDN, without significant relation to SBP and HR. These findings suggest a direct effect of altered sympathetic activity in addition to unloading on cardiac hypertrophy and function. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation
- Author
-
Schirmer, Stephan H., Werner, Christian M., Binder, Stephan B.G., Faas, Maria E., Custodis, Florian, Böhm, Michael, and Laufs, Ulrich
- Subjects
- *
OMEGA-3 fatty acids , *TRIGLYCERIDES , *MONOCYTES , *CARDIOVASCULAR disease treatment , *PLACEBOS , *CHEMOKINES , *CIRCADIAN rhythms - Abstract
Abstract: Objective: Epidemiologic studies suggest that elevated postprandial triglycerides (ppTG) are associated with future cardiovascular events. Monocyte activation plays an important role in vascular diseases. Omega-3 fatty acids (n3-FA) lower fasting TG levels. The effects of n3-FA on ppTG and the role of ppTG for monocyte activation are insufficiently understood. Methods and results: 23 healthy volunteers and 30 non-diabetic patients with documented coronary artery disease were subjected to an oral TG tolerance test (OTTT) consisting of 80 g cream fat or to water as control (H2O). Patients were treated with 4 g n3-FA/day or placebo for 3 weeks in a randomized, placebo-controlled, double-blind, crossover study. Relative postprandial TG increase reached its maximum 4 h after fat intake (185.1 ± 10.9% of baseline). n3-FA reduced fasting TG from 137.1 ± 12.9 to 112.2 ± 8.6 mg/dl (p < 0.05), and maximum ppTG concentrations from 243.6 ± 24.6 to 205.8 ± 17.1 mg/dl (p < 0.05), while relative TG increase (192.8 ± 12.7%) was comparable to placebo. Relative monocytopenia and neutrophilia were detected following fat intake, which was unaffected by n3-FA and also detectable in the H2O group. Serum chemotactic cytokine (MCP1 and fractalkine) concentrations and monocyte migration were not affected by fat intake or n3-FA. Monocyte activation markers CD11b and CD14, monocyte subpopulations CD16+CD14high and CD16+CD14low, sICAM serum levels and markers of oxidative stress remained unchanged by fat intake or n3-FA. Conclusion: The postprandial TG increase does not stimulate monocytes beyond their circadian activation patterns. n3-FA reduce fasting TG and the postprandial TG increase. n3-FA may therefore allow to prospectively study whether selected patients benefit from TG-lowering independent of LDL- and HDL-cholesterol. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
6. Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Clinical Evidence and Future Developments
- Author
-
Schirmer, Stephan H., Baumhäkel, Magnus, Neuberger, Hans-Ruprecht, Hohnloser, Stefan H., van Gelder, Isabelle C., Lip, Gregory Y.H., and Böhm, Michael
- Subjects
- *
ANTICOAGULANTS , *CEREBROVASCULAR disease prevention , *ATRIAL fibrillation , *ASPIRIN , *VITAMIN K , *DRUG efficacy , *ANTITHROMBINS - Abstract
Atrial fibrillation (AF) is the most common cardiac rhythm disorder and a major risk factor for ischemic stroke. Antithrombotic therapy using aspirin or vitamin K antagonists (VKA) is currently prescribed for prevention for ischemic stroke in patients with AF. A narrow therapeutic range and the need of regular monitoring of its anticoagulatory effect impair effectiveness and safety of VKA, causing a need for alternative anticoagulant drugs. Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban. Currently, data from a phase III clinical trial are available for dabigatran only, which show the direct thrombin antagonist to be at least noninferior in efficacy to VKA for the prevention of stroke and systemic embolism in patients with AF. This review focuses on current advances in the development of directly acting oral anticoagulant drugs and their potential to replace the VKA class of drugs in patients with AF. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
7. Vascular Pathophysiology in Response to Increased Heart Rate
- Author
-
Custodis, Florian, Schirmer, Stephan H., Baumhäkel, Magnus, Heusch, Gerd, Böhm, Michael, and Laufs, Ulrich
- Subjects
- *
CARDIOVASCULAR diseases , *PATIENTS , *PATHOLOGICAL physiology , *HEART beat , *HYPERTENSION , *MYOCARDIAL infarction , *ATHEROSCLEROSIS , *LITERATURE reviews ,CARDIOVASCULAR disease related mortality - Abstract
This review summarizes the current literature and the open questions regarding the physiology and pathophysiology of the mechanical effects of heart rate on the vessel wall and the associated molecular signaling that may have implications for patient care. Epidemiological evidence shows that resting heart rate is associated with cardiovascular morbidity and mortality in the general population and in patients with cardiovascular disease. As a consequence, increased resting heart rate has emerged as an independent risk factor both in primary prevention and in patients with hypertension, coronary artery disease, and myocardial infarction. Experimental and clinical data suggest that sustained elevation of heart rate—independent of the underlying trigger—contributes to the pathogenesis of vascular disease. In animal studies, accelerated heart rate is associated with cellular signaling events leading to vascular oxidative stress, endothelial dysfunction, and acceleration of atherogenesis. The underlying mechanisms are only partially understood and appear to involve alterations of mechanic properties such as reduction of vascular compliance. Clinical studies reported a positive correlation between increased resting heart rate and circulating markers of inflammation. In patients with coronary heart disease, increased resting heart rate may influence the clinical course of atherosclerotic disease by facilitation of plaque disruption and progression of coronary atherosclerosis. While a benefit of pharmacological or interventional heart rate reduction on different vascular outcomes was observed in experimental studies, prospective clinical data are limited, and prospective evidence determining whether modulation of heart rate can reduce cardiovascular events in different patient populations is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
8. Blocking Interferon β Stimulates Vascular Smooth Muscle Cell Proliferation and Arteriogenesis.
- Author
-
Schirmer, Stephan H., Bot, Pieter T., Fledderus, Joost O., van der Laan, A. M., Volger, Oscar L., Laufs, Ulrich, Böhm, Michael, de Vries, Carlie J. M., Horrevoets, Anton J. G., Piek, Jan J., Hoefer, Imo E., and van Royen, Niels
- Subjects
- *
CELL proliferation , *CELL cycle , *MUSCLE cells , *APOPTOSIS , *VASCULAR smooth muscle , *INTERFERONS , *LABORATORY mice - Abstract
Increased interferon (IFN)-β signaling in patients with insufficient coronary collateralization and an inhibitory effect of IFNβ on collateral artery growth in mice have been reported. The mechanisms of IFNβ-induced inhibition of arteriogenesis are unknown. In stimulated monocytes from patients with chronic total coronary artery occlusion and decreased arteriogenic response, whole genome expression analysis showed increased expression of IFNβ-regulated genes. Immunohistochemically, the IFNβ receptor was localized in the vascular media of murine collateral arteries. Treatment of vascular smooth muscle cells (VSMC) with IFNβ resulted in an attenuated proliferation, cell-cycle arrest, and increased expression of cyclin-dependent kinase inhibitor-1A (p21). The growth inhibitory effect of IFNβ was attenuated by inhibition of p21 by RNA interference. IFNβ-treated THP1 monocytes showed enhanced apoptosis. Subsequently, we tested if collateral artery growth can be stimulated by inhibition of IFNβ-signaling. RNA interference of the IFNβ receptor-1 (IFNAR1) increased VSMC proliferation, cell cycle progression, and reduced p21 gene expression. IFNβ signaling and FAS and TRAIL expression were attenuated in monocytes from IFNAR1-/- mice, indicating reduced monocyte apoptosis. Hindlimb perfusion restoration 1 week after femoral artery ligation was improved in IFNAR1-/- mice compared with wild-type mice as assessed by infusion of fluorescent microspheres. These results demonstrate that IFNβ inhibits collateral artery growth and VSMC proliferation through p21-dependent cell cycle arrest and induction of monocyte apoptosis. Inhibition of IFNβ stimulates VSMC proliferation and collateral artery growth. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
9. Local Cytokine Concentrations and Oxygen Pressure Are Related to Maturation of the Collateral Circulation in Humans
- Author
-
Schirmer, Stephan H., van Royen, Niels, Moerland, Perry D., Fledderus, Joost O., Henriques, José P., van der Schaaf, René J., Vis, Marije M., Baan, Jan, Koch, Karel T., Horrevoets, Anton J.G., Hoefer, Imo E., and Piek, Jan J.
- Subjects
- *
CYTOKINES , *OXYGEN in the body , *BODY fluid pressure , *MATURATION (Psychology) , *COLLATERAL circulation , *CORONARY disease , *HUMAN biology - Abstract
Objectives: Our aim was to determine cytokine and oxygen gradients over the collateral circulation in humans. Background: The molecular background of the maturation of the collateral circulation in response to coronary narrowing is poorly understood in humans, partly because of difficulties in obtaining local samples from the human collateral circulation. Methods: Coronary collateral blood was sampled in 60 patients with nontotal (n = 25) or total coronary occlusions (n = 35) using a special wide-lumen catheter. Coronary collateral flow index (CFI) was assessed by intracoronary pressure measurements. Oxygenation and lactate content was measured as well as 30 cytokines potentially involved in collateral artery growth, using a custom-made multiplex assay. Results: No rise in lactate or change in pH was found in collateral blood. Oxygen gradient between coronary and collateral arterial blood correlated inversely with CFI (r = −0.61, p < 0.001). Locally increased plasma levels were found for basic fibroblast growth factor, eotaxin, macrophage migration inflammatory factor, monocyte chemoattractant protein-1, and transforming growth factor-beta, while stem cell factor and stem cell growth factor-beta were significantly decreased. The highest cytokine gradients were found in patients with the least developed collateral circulation. The majority of cytokines correlated more strongly with the pO2 gradient across the collateral bed than with CFI. Conclusions: Intravascular ischemia during brief balloon coronary occlusion is absent in human coronary collateral arteries. The oxygen gradient found over the collateral circulation is increased in patients with a less matured collateral circulation and relates to local levels of several known pro-arteriogenic cytokines. In case of a more developed collateral circulation, relatively low levels of cytokines are present, suggesting that growth factor therapy might be beneficial at this stage. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
10. Reply: Sympathetic and Autonomic Effects of Renal Denervation on Atrial Remodeling and Atrial Arrhythmias.
- Author
-
Schirmer, Stephan H., Linz, Dominik, Mahfoud, Felix, and Böhm, Michael
- Published
- 2015
- Full Text
- View/download PDF
11. Reply
- Author
-
Custodis, Florian, Schirmer, Stephan H., Baumhäkel, Magnus, Heusch, Gerd, Böhm, Michael, and Laufs, Ulrich
- Published
- 2011
- Full Text
- View/download PDF
12. Monocyte heterogeneity in human cardiovascular disease
- Author
-
Zawada, Adam M., Rogacev, Kyrill S., Schirmer, Stephan H., Sester, Martina, Böhm, Michael, Fliser, Danilo, and Heine, Gunnar H.
- Subjects
- *
CARDIOVASCULAR disease diagnosis , *MONOCYTES , *ATHEROSCLEROSIS , *INFLAMMATION , *MACROPHAGES , *HETEROGENEITY , *IMMUNOREGULATION - Abstract
Abstract: Atherosclerosis has been characterized as an inflammatory process, in which monocytes and monocyte-derived macrophages are of paramount importance. Contrasting with their established role in atherosclerosis, monocytes have not unanimously been found to predict cardiovascular events in large epidemiological studies. However, in these studies human monocyte heterogeneity has been largely overlooked so far. Three human monocyte subsets can be distinguished: classical CD14++CD16−, intermediate CD14++CD16+ and nonclassical CD14+CD16++ monocytes. Of note, correct enumeration of subset counts requires appropriate staining and gating strategies that encompass a pan-monocytic marker (e.g. HLA-DR or CD86). In experimental studies on murine atherogenesis a monocyte subset-specific contribution to atherosclerosis has been established. However, major interspecies differences in atherogenesis itself, as well as in the immune system (including monocyte subset phenotype and distribution) preclude a direct extrapolation to human pathology. Experimental and pilot clinical studies point to a prominent involvement of intermediate CD14++CD16+ monocytes in human atherosclerosis. Future clinical studies should analyze monocyte heterogeneity in cardiovascular disease. If a specific contribution of intermediate monocytes should be confirmed, immunomodulation of this monocyte subset could represent a future therapeutic target in atherosclerosis. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
13. Plant sterol ester diet supplementation increases serum plant sterols and markers of cholesterol synthesis, but has no effect on total cholesterol levels.
- Author
-
Weingärtner, Oliver, Bogeski, Ivan, Kummerow, Carsten, Schirmer, Stephan H., Husche, Constanze, Vanmierlo, Tim, Wagenpfeil, Gudrun, Hoth, Markus, Böhm, Michael, Lütjohann, Dieter, and Laufs, Ulrich
- Subjects
- *
PLACEBOS , *ESTERS , *CHEMICAL synthesis , *MARGARINE , *STEROLS analysis , *HYPERCHOLESTEREMIA diagnosis - Abstract
This double-blind, randomized, placebo-controlled, cross-over intervention-study was conducted in healthy volunteers to evaluate the effects of plant sterol ester supplemented margarine on cholesterol, non-cholesterol sterols and oxidative stress in serum and monocytes. Sixteen volunteers, average age 34 years, with no or mild hypercholesterolemia were subjected to a 4 week period of daily intake of 3 g plant sterols per day supplied via a supplemented margarine on top of regular eating habits. After a wash-out period of one week, volunteers switched groups. Compared to placebo, a diet supplementation with plant sterols increased serum levels of plant sterols such as campesterol (+0.16 ± 0.19 mg/dL, p = 0.005) and sitosterol (+0.27 ± 0.18 mg/dL, p < 0.001) and increased markers of cholesterol synthesis such as desmosterol (+0.05 ± 0.07 mg/dL, p = 0.006) as well as lathosterol (+0.11 ± 0.16 mg/dL, p = 0.012). Cholesterol serum levels, however, were not changed significantly (+18.68 ± 32.6 mg/dL, p = 0.052). These findings could not be verified in isolated circulating monocytes. Moreover, there was no effect on monocyte activation and no differences with regard to redox state after plant sterol supplemented diet. Therefore, in a population of healthy volunteers with no or mild hypercholesterolemia, consumption of plant sterol ester supplemented margarine results in increased concentrations of plant sterols and cholesterol synthesis markers without affecting total cholesterol in the serum, activation of circulating monocytes or redox state. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
14. Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial.
- Author
-
Böhm, Michael, Ezekowitz, Michael D., Connolly, Stuart J., Eikelboom, John W., Hohnloser, Stefan H., Reilly, Paul A., Schumacher, Helmut, Brueckmann, Martina, Schirmer, Stephan H., Kratz, Mario T., Yusuf, Salim, Diener, Hans-Christoph, Hijazi, Ziad, and Wallentin, Lars
- Subjects
- *
KIDNEY function tests , *ATRIAL fibrillation , *VITAMIN K , *CALCIFICATION , *GLOMERULAR filtration rate , *DRUG therapy , *WARFARIN , *ATRIAL fibrillation treatment , *PATIENTS - Abstract
Background Vitamin K–dependent factors protect against vascular and renovascular calcification, and vitamin K antagonists may be associated with a decreased glomerular filtration rate (GFR). Objectives This study analyzed changes in GFR during long-term treatment with warfarin or dabigatran etexilate (DE) in patients enrolled in the RE-LY (Randomized Evaluation of Long Term Anticoagulation Therapy) trial. Methods Of the 18,113 patients in the RE-LY study randomized to receive DE (110 mg or 150 mg twice daily) or warfarin, 16,490 patients with atrial fibrillation had creatinine values measured at baseline and at least 1 follow-up visit. Changes in GFR for up to 30 months were evaluated. Results GFR declined in all treatment groups. After an average of 30 months, the mean ± SE decline in GFR was significantly greater with warfarin (–3.68 ± 0.24 ml/min) compared with DE 110 mg (–2.57 ± 0.24 ml/min; p = 0.0009 vs. warfarin) and DE 150 mg (–2.46 ± 0.23 ml/min; p = 0.0002 vs. warfarin). A decrease in GFR >25% was less likely with DE 110 mg (hazard ratio: 0.81 [95% confidence interval: 0.69 to 0.96]; p = 0.017) or DE 150 mg (hazard ratio: 0.79 [95% confidence interval: 0.68 to 0.93]; p = 0.0056) than with warfarin in the observation period >18 months. Patients with poor international normalized ratio control (i.e., time in therapeutic range <65%) exhibited a faster decline in GFR. A more pronounced decline in GFR was associated with previous warfarin use and with the presence of diabetes. Conclusions Patients with atrial fibrillation receiving oral anticoagulation exhibited a decline in renal function that was greater in those taking warfarin versus DE, and it was amplified by diabetes and previous vitamin K antagonist use. (Randomized Evaluation of Long Term Anticoagulant Therapy [RE-LY] With Dabigatran Etexilate; NCT00262600 ) [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
15. Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension
- Author
-
Brandt, Mathias C., Mahfoud, Felix, Reda, Sara, Schirmer, Stephan H., Erdmann, Erland, Böhm, Michael, and Hoppe, Uta C.
- Subjects
- *
CARDIAC hypertrophy , *BLOOD pressure , *ECHOCARDIOGRAPHY , *BODY mass index , *LEFT heart ventricle , *HYPERTENSION - Abstract
Objectives: This study investigated the effect of catheter-based renal sympathetic denervation (RD) on left ventricular hypertrophy (LVH) and systolic and diastolic function in patients with resistant hypertension. Background: LVH and diastolic dysfunction are associated with elevated sympathetic activity and increased morbidity and mortality. The effect of RD on LVH and LV function is unclear. Methods: Forty-six patients underwent bilateral RD, and 18 patients served as controls. Transthoracic echocardiography was performed at baseline, and after 1 month and 6 months. Results: Besides reduction of systolic and diastolic blood pressure (−22.5/−7.2 mm Hg at 1 month and −27.8/−8.8 mm Hg at 6 months, p < 0.001 at each time point), RD significantly reduced mean interventricular septum thickness from 14.1 ± 1.9 mm to 13.4 ± 2.1 mm and 12.5 ± 1.4 mm (p = 0.007), and LV mass index from 53.9 ± 15.6 g/m2.7 (112.4 ± 33.9 g/m2) to 47.0 ± 14.2 g/m2.7 (103.6 ± 30.5 g/m2) and 44.7 ± 14.9 g/m2.7 (94.9 ± 29.8 g/m2) (p < 0.001) at 1 month and 6 months, respectively. The mitral valve lateral E/E′ decreased after RD from 9.9 ± 4.0 to 7.9 ± 2.2 at 1 month and 7.4 ± 2.7 at 6 months (p < 0.001), indicating reduction of LV filling pressures. Isovolumic relaxation time shortened (baseline 109.1 ± 21.7 ms vs. 85.6 ± 24.4 ms at 6 months, p = 0.006), whereas ejection fraction significantly increased after RD (baseline: 63.1 ± 8.1% vs. 70.1 ± 11.5% at 6 months, p < 0.001). No significant changes were obtained in control patients. Conclusions: Besides the known effect on blood pressure, our study showed for the first time that RD significantly reduces LV mass and improves diastolic function, which might have important prognostic implications in patients with resistant hypertension at high cardiovascular risk. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
16. Leukocyte subpopulations and arteriogenesis: Specific role of monocytes, lymphocytes and granulocytes
- Author
-
Hoefer, Imo E., Grundmann, Sebastian, van Royen, Niels, Voskuil, Michiel, Schirmer, Stephan H., Ulusans, Susann, Bode, Christoph, Buschmann, Ivo R., and Piek, Jan J.
- Subjects
- *
LEUCOCYTES , *INTERLEUKIN-8 , *ARTERIAL occlusions , *IMMUNOHISTOCHEMISTRY - Abstract
Abstract: Objective:: Circulating leukocytes play a crucial role during arteriogenesis. However, known pro-arteriogenic compounds (MCP-1, GM-CSF) acting via monocytic pathways also exert positive effects on granulocytes and lymphocytes. The role of these two cell types in arteriogenesis remains yet to be clarified, which was the aim of the current study. Methods:: Ninety New Zealand White Rabbits received either phosphate buffered saline (PBS), monocyte chemoattractant protein-1 (MCP-1), interleukin-8 (IL-8), neutrophil activating protein-2 (NAP-2) or lymphotactin (Ltn) via osmotic minipumps after unilateral femoral artery ligation. In vitro stimulation and in vivo assessment of chemoattraction confirmed cell-specific action of the compounds in rabbits. Arteriogenesis was evaluated by angiography and collateral conductance measurements using fluorescent microspheres. Quantitative immunohistology was used to quantify transmigrated leukocyte subtypes after infusion of the factors. Results:: MCP-1 infusion attracts monocytes and granulocytes, whereas IL-8 attracts all three cell types albeit monocytes to a significantly lower degree than MCP-1. NAP-2 and lymphotactin selectively attract granulocytes, respectively, lymphocytes. Of the tested cytokines, only MCP-1 stimulates arteriogenesis, as assessed by collateral conductance measurements ((ml/(min100mmHg)): PBS, 50.70±5.15; MCP-1, 216.30±12.30; IL-8, 58.91±5.56; NAP-2, 66.83±8.72; Ltn, 52.80±5.37) and angiographic findings. Conclusion:: This study for the first time provides evidence that not granulocytes or T-lymphocytes but monocytes are the key mediators of arteriogenesis. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
17. Effects of edoxaban and warfarin on vascular remodeling: Atherosclerotic plaque progression and collateral artery growth.
- Author
-
Millenaar, Dominic, Bachmann, Philipp, Böhm, Michael, Custodis, Florian, and Schirmer, Stephan H.
- Subjects
- *
VASCULAR remodeling , *COLLATERAL circulation , *ATHEROSCLEROTIC plaque , *WARFARIN , *SINUS of valsalva , *FEMORAL artery , *VASCULAR smooth muscle , *AORTA , *EDOXABAN - Abstract
Oral anticoagulation prevents thromboembolism in atrial fibrillation. Factor Xa inhibitors, like edoxaban, are known to reduce inflammation and proliferation of smooth muscle cells, while vitamin K antagonism can cause vascular calcific damage. The influence of edoxaban compared to warfarin on vascular remodeling, atherosclerosis and arteriogenesis is unknown. Apolipoprotein E knockout (ApoE −/−) mice were fed cholesterol-rich diet alone (control, co), with warfarin+vitamin K1 (warf) or with edoxaban (Edo) for 8 weeks. After 6 weeks, femoral artery ligation was performed. There was no difference in hind-limb perfusion restoration between the three groups after 14 days (Co 0.36 ± 0.05 vs. Warf 0.39 ± 0.09 (p =.39), Co vs. Edo 0.51 ± 0.06 (p =.089), Warf vs. Edo (p =.83)) after ligation. Immuno-histologically, there was no difference in smooth muscle cell count in both hindlimbs between the three groups or in the amount of perivascular macrophages in collateral-bearing hindlimb tissue. Edoxaban showed the lowest amount of plaque tissue in the aortic sinus tissue (Co 74 ± 11% vs. Edo 62 ± 12% (p =.024), Co vs. Warf 69 ± 14% (p =.30), Edo vs. Warf (p =.14)) as well as the least amount of fibrosis (Co 3.1 ± 0.9% vs. Edo 1.7 ± 0.6% (p =.027), Co vs. Warf 4.1 ± 0.7% (p =.081), Edo vs. Warf (p <.001)). No difference in mRNA content of inflammatory cytokines in muscle tissue or spleen was detected between the three groups. These data suggest that treatment with edoxaban unlike warfarin prevents vascular maladaptive remodeling, which may be clinically important. Unlabelled Image • Warfarin leads to increased fibrosis in the aortic sinus of ApoE −/− mice compared to placebo. • Edoxaban reduces collagen content as well as atherosclerotic plaque lesions compared to placebo. • No changes in collateral artery growth was apparent following treatment with warfarin or edoxaban. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. Reply: Anticoagulant-Related Nephropathy.
- Author
-
Böhm, Michael, Ezekowitz, Michael D., Connolly, Stuart J., Eikelboom, John W., Hohnloser, Stefan H., Reilly, Paul A., Schumacher, Helmut, Brueckmann, Martina, Schirmer, Stephan H., Kratz, Mario T., Yusuf, Salim, Diener, Hans-Christoph, Hijazi, Ziad, and Wallentin, Lars
- Subjects
- *
ANTICOAGULANTS , *KIDNEY diseases , *KIDNEY disease treatments , *ATRIAL fibrillation treatment , *NEPHROTOXICOLOGY , *PATIENTS , *ATRIAL fibrillation diagnosis , *KIDNEY physiology , *ATRIAL fibrillation , *GLOMERULAR filtration rate - Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.